Among the DEGs, ERBB3 overlapped in the PI3K/AKT and MAPK signaling pathways (Figure 4A), which is involved in the progression and metastasis of ovarian cancer and many other cancers (32–37). Here, ERBB3 is linked to ovarian cancer.